Does tamoxifen prophylaxis for breast cancer provide long-term prevention?

被引：0
作者：
Bonanni, Bernardo [1 ]
Lazzeroni, Matteo [1 ]
Veronesi, Umberto [1 ]
机构：
[1] Ist Europeo Oncol, Div Canc Prevent & Genet, I-20141 Milan, Italy
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 10期
关键词：
breast cancer; post-treatment effects; prophylaxis; tamoxifen;
D O I：
10.1038/ncponc0933
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：568 / 569
页数：2
相关论文
共 50 条
[21]   TAMOXIFEN AND BREAST-CANCER - FROM PALLIATION TO PREVENTION [J].
RICH, SE .
CANCER NURSING, 1993, 16 (05) :341-346
[22]   Long-term follow-up of postmenopausal breast cancer patients following discontinuation of tamoxifen therapy [J].
Markovitch, O. ;
Tepper, R. ;
Fishman, A. ;
Aviram, R. ;
Cohen, Ilan .
MATURITAS, 2008, 59 (04) :387-393
[23]   Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up [J].
Fohlin, Helena ;
Nordenskjold, Anna ;
Rosell, Johan ;
Ferno, Marten ;
Fornander, Tommy ;
Ryden, Lisa ;
Skoog, Lambert ;
Nordenskjold, Bo ;
Stal, Olle .
ACTA ONCOLOGICA, 2024, 63 :535-541
[24]   Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer [J].
Nordenskjold, Anna ;
Fohlin, Helena ;
Fornander, Tommy ;
Lofdahl, Britta ;
Skoog, Lambert ;
Stal, Olle .
BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) :313-322
[25]   Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer [J].
Anna Nordenskjöld ;
Helena Fohlin ;
Tommy Fornander ;
Britta Löfdahl ;
Lambert Skoog ;
Olle Stål .
Breast Cancer Research and Treatment, 2016, 160 :313-322
[26]   Sexual functioning and mood not affected by long-term tamoxifen [J].
Reactions Weekly, 2001, 846 (1) :5-5
[27]   Adherence to long-term adjuvant hormonal therapy for breast cancer [J].
Gotay, Carolyn ;
Dunn, Julia .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (06)
[28]   Is long-term adjuvant treatment of breast cancer with anastrozole indicated? [J].
Doggrell, Sheila A. .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (09) :1619-1622
[29]   Tolerance of Tamoxifen as an adjuvant therapy and long-term follow up of 55 premenopausal breast cancer women, cared for at the Institut de cancerologie de Lorraine, treated with Tamoxifen [J].
Sebaoun, Perle ;
Frederic, Marchal ;
Weryha, Georges ;
El Hamdaoui, Sara ;
Salleron, Julia ;
Lesur, Anne .
BULLETIN DU CANCER, 2019, 106 (12) :S75-S91
[30]   A CURRENT VIEW OF TAMOXIFEN FOR THE TREATMENT AND PREVENTION OF BREAST-CANCER [J].
JORDAN, VC .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (02) :507-517
12345